IDEXX Laboratories, Inc.

IDEXX Laboratories Beats on EPS, Stock Down 14.5%

IDEXX Laboratories reported an EPS of $0.42, beating expectations slightly. However, the stock fell by 14.5% in reaction, which may indicate investor concerns despite the earnings beat. The lack of revenue data and guidance could have contributed to the negative stock movement.